Endpoints News 26. Nov. 2025 Imfinzi's latest label expansion; FDA seeks more information on BiomX's nebulizer
Endpoints News 26. Nov. 2025 China's Zhongmou seeks to create a ‘one-size-fits-all’ rival to Luxturna
Endpoints News 25. Nov. 2025 CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second round